- Grupo Sura reported a fourth-quarter net income of COP 395.80 billion, which is a decrease of 2.5% compared to the previous year.
- The company saw an increase in net premiums written, reaching COP 5.91 trillion, up by 5.8% year over year.
- For 2025, Grupo Sura has set a guidance for controlling interest net income between 1.7 trillion and 1.9 trillion Colombian pesos following a spinoff.
- The expected earnings per share (EPS) for 2025 is projected to be between 5,200 and 5,800 pesos.
- Grupo Sura aims for an adjusted return on equity of 10% to 11% in 2025.
- Analyst recommendations for Grupo Sura include 1 buy rating, 3 hold ratings, and 2 sell ratings.
A look at Grupo de Inversiones Suramericana Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Grupo de Inversiones Suramericana, a company with a diverse portfolio mainly focused on strategic investments in the financial, insurance, and social security sectors, is showing a promising long-term outlook based on the Smartkarma Smart Scores. With strong scores in Growth and Momentum, indicating high potential for future expansion and strong market performance, Grupo de Inversiones Suramericana is positioned well for growth opportunities. Additionally, the company’s solid scores in Value and Resilience suggest stability and a sound investment choice for those seeking long-term prospects.
Despite having a lower score in Dividend, Grupo de Inversiones Suramericana‘s overall outlook appears positive, bolstered by its robust performance in key areas crucial for sustained growth. Investors looking for a company with strong growth potential and resilience in various economic conditions may find Grupo de Inversiones Suramericana to be an attractive investment option in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
